ipharmaservicesApr 13Colorectal cancer | News | Media | UpdatesApril 08, 2024 Krazati plus cetuximab showed improvement in objective response rate in patients with KRASG12C-mutated CRC Mirati...
ipharmaservicesApr 3FDA Devices Approval | 2024 | Abbott News | iPharmaCenterApril 02, 2024 Abbott Secures FDA Nod for Triclip, Novel Tool for Mending Faulty Tricuspid Heart Valve Abbott revealed that the U.S. Food...